The New York startup scene undoubtedly plays a crucial role in instigating some incredible innovation in several industries, and health diagnostics is no exception. There are an array of promising health diagnostic startups currently emerging from the city, increasingly employing state-of-the-art technologies to detect, interpret, and monitor health conditions. Whether it’s through transformative solutions for peripheral artery disease treatments, advancements in cancer diagnostics, or reinventing ways to treat chronic diseases, New York’s health diagnostic startups are playing a critical role in revolutionizing patient treatment and care.
With an express need for more efficient and effective methods of diagnosing and treating health conditions, the diagnosis-focused startups within the healthcare sector are making notable strides in accessing and interpreting health data, ultimately aiming to improve patient outcomes on a global scale. So, let’s take a closer look at some of the promising startups making waves in this field, all of which are contributing to New York’s vibrant tech ecosystem.
In this roundup, we will examine fifteen health diagnostic startups that are based in New York, providing a closer look at their unique offerings. The fact that this list is dominated by health tech companies perhaps reflects the changing landscape of the healthcare industry, increasingly characterized by digital transformation and innovation.
Monument
Monument is a healthcare startup providing an online platform for alcohol addiction treatment. It exists to provide support and therapy for those striving to redefine their relationship with alcohol. The platform was founded by Amit Klein, Justin Geller, and Mike Russell.
HiberCell
Focusing on the biotechnology sector, HiberCell is a clinical-stage company dedicated to the development of novel therapeutic treatments related to adaptive stress. Alan Rigby, Ari Nowacek, and Julio Aguirre-Ghiso are the founders of HiberCell.
C2i Genomics
Specializing in genetic services, C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations. Asaf Zviran, Boris Oklander, and Dan Landau are the pillars behind the foundation of C2i Genomic.
Woolsey Pharmaceuticals
A Biotech company, Woolsey Pharmaceuticals focuses on reinventing ways to handle and treat the world’s most challenging diseases. The company was brought to life by David M. Geliebter and Sven M. Jacobson.
AccurKardia
AccurKardia offers automated ECG analytics and was founded by John Fox, Juan C Jimenez, and Naveen Srinivas.
Heywear
Heywear provides prescription eyewear and eye-care services via a tech-enabled optical studio. It was founded by Alexandre Jais, Corentin Macias, and Idan Cohen.
Episteme Prognostics
Episteme Prognostics is a precision medicine company that develops therapeutic biomarkers for pancreatic cancer. It was founded by Steven Leach and Surajit Dhara
Columbia University Department of Ophthalmology
The Columbia University Department of Ophthalmology offers innovative and comprehensive eye-care services.
mPOD
mPOD develops medical tools for diagnostics aimed at enhancing patient care and health outcomes.
pgool
pgool is an AI startup that has designed a tool for pill recognition, founded by Max Savenko.
ZiphyCare
ZiphyCare offers tools for remote patient triage, scheduling, examination, and communication. Its founders are Daniel Kogan, Gene Ukrainsky, and Rada Sumareva.
Pearl Health
Pearl Health provides an integrated platform to help primary care providers give attention to the patients who need it most. Its founders are Ankit Patel, Jeff De Flavio, and Michael Kopko.
Ozette Technologies
Ozette is a life sciences data startup that utilizes artificial intelligence, founded by Ali Ansary, Evan Greene, and Greg Finak.
Tripment Health
Tripment Health is a digital health startup offering consumers affordable diagnostic imaging and laboratory services. It was founded by Alex Radunsky, Julia Radunsky, and Vlad Yushvah.
River 3 Renal
River 3 Renal develops novel therapies designed to target orphan diseases in the renal space.
Ready to amplify your reach and engage with the most dynamic community in the venture world? Consider sponsoring an article with us. Learn more about our promotional opportunities and sponsored articles here.
Your story could be the next big hit on US Venture News!
Follow Us